Large local reactions to Hymenoptera stings: Outcome of re-stings in real life.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
10 2019
Historique:
received: 05 02 2019
revised: 08 04 2019
accepted: 11 04 2019
pubmed: 11 5 2019
medline: 20 8 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Large local reaction to Hymenoptera stings is usually defined as a swelling >10 cm which lasts longer than 24 hours, sometimes associated with erythema, pruritus and blisters. Currently, the risk of subsequent systemic reactions after re-stings is considered low (2%-15%). Therefore, a diagnostic workup in case of large local reaction is often judged unnecessary, as well as adrenaline auto-injector and venom immunotherapy prescription. The aim of this study was to prospectively evaluate the outcome of re-stings in a real-world setting, in patients with a history of one previous large local reaction. We consecutively enrolled patients who experienced their first large local reaction (as per EAACI definition), treated with antihistamine and steroids. They were followed for field re-stings and assessed for risk of subsequent systemic reactions. We enrolled 662 patients. Out of the 225 re-stung subjects, 24% did not experience reactions, 52% reported a second large local reaction and 24% had systemic reactions. The risk of subsequent systemic reactions was higher in case of skin test reactivity to Apis mellifera or Vespula species (OR 2.1 and 3.8, respectively), in particular if positive at 0.001 µg/mL concentration (OR 13.4 and 16.5, respectively). Systemic reactions, after a previous large local reaction, occur more frequently than that reported by literature. After analysing the predictive role of large local reactions for systemic reactions, we demonstrated that an accurate diagnostic workup may be considered, particularly skin tests. Further studies in different countries are needed to confirm these results and large local reaction management.

Sections du résumé

BACKGROUND
Large local reaction to Hymenoptera stings is usually defined as a swelling >10 cm which lasts longer than 24 hours, sometimes associated with erythema, pruritus and blisters. Currently, the risk of subsequent systemic reactions after re-stings is considered low (2%-15%). Therefore, a diagnostic workup in case of large local reaction is often judged unnecessary, as well as adrenaline auto-injector and venom immunotherapy prescription. The aim of this study was to prospectively evaluate the outcome of re-stings in a real-world setting, in patients with a history of one previous large local reaction.
METHODS
We consecutively enrolled patients who experienced their first large local reaction (as per EAACI definition), treated with antihistamine and steroids. They were followed for field re-stings and assessed for risk of subsequent systemic reactions.
RESULTS
We enrolled 662 patients. Out of the 225 re-stung subjects, 24% did not experience reactions, 52% reported a second large local reaction and 24% had systemic reactions. The risk of subsequent systemic reactions was higher in case of skin test reactivity to Apis mellifera or Vespula species (OR 2.1 and 3.8, respectively), in particular if positive at 0.001 µg/mL concentration (OR 13.4 and 16.5, respectively).
CONCLUSIONS
Systemic reactions, after a previous large local reaction, occur more frequently than that reported by literature. After analysing the predictive role of large local reactions for systemic reactions, we demonstrated that an accurate diagnostic workup may be considered, particularly skin tests. Further studies in different countries are needed to confirm these results and large local reaction management.

Identifiants

pubmed: 31074868
doi: 10.1111/all.13863
doi:

Substances chimiques

Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1969-1976

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Références

Bilo BM, Rueff F, Mosbech H, et al. Diagnosis of Hymenoptera venom allergy. Allergy. 2005;60:1339-1349.
Severino M, Bonadonna P, Passalacqua G. Large local reactions from stinging insects: from epidemiology to management. Curr Opin Allergy Clin Immunol. 2009;9:334-337.
Bilò MB, Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy. 2009;39:1467-1476.
Sturm GJ, Kranzelbinder B, Schuster C, et al. Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare. J Allergy Clin Immunol. 2014;133(1635-43):1635-1643.e1.
Golden D, Demain J, Freeman T, et al. Stinging insect hypersensitivity. Ann Allergy, Asthma Immunol. 2017;118:28-54.
Graft DF, Schuberth KC, Kagey-Sobotka A, et al. A prospective study of the natural history of large local reactions after Hymenoptera stings in children. J Pediatr. 1984;104:664-668.
Mauriello PM, Barde SH, Georgitis JW, Reisman RE. Natural history of large local reactions from stinging insects. J Allergy Clin Immunol. 1984;74:494-498.
Golden D, Kagey-Sobotka A, Norman PS, Hamilton RG, Lichtenstein LM. Outcomes of Allergy to Insect Stings in Children, with and without Venom Immunotherapy. N Engl J Med. 2004;351:668-674.
Golden D, Breisch NL, Hamilton RG, et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol. 2006;117:670-675.
Pucci S, D’Alò S, De Pasquale T, Illuminati I, Makri E, Incorvaia C. Risk of anaphylaxis in patients with large local reactions to hymenoptera stings: a retrospective and prospective study. Clin Mol Allergy. 2015;13:21.
Bilò MB, Pravettoni V, Bignardi D, et al. Hymenoptera Venom Allergy: Management of children and adults in clinical practice. J Investig Allergol Clin Immunol. 2018;29. https://doi.org/10.18176/jiaci.0310
Bilò MB, Cichocka-Jarosz E, Pumphrey R, et al. Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement. Allergy Eur. J Allergy Clin Immunol. 2016;71(7):931-943.
Sturm GJ, Varga EM, Roberts G, et al. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy. Allergy. Eur J Allergy Clin Immunol. 2018;73: 744-764. https://onlinelibrary.wiley.com/doi/full/10.1111/all.13262
Golden D. Large Local Reactions to Insect Stings. J Allergy Clin Immunol Pract. 2015;3:331-334.
Severino MG, Cortellini G, Bonadonna P, et al. Sublingual immunotherapy for large local reactions caused by honeybee sting: A double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2008;122:44-48.
Mueller HL. Diagnosis and treatment of insect sensitivity. J Asthma Res. 1966;3:331-333.
Sturm GJ, Heinemann A, Schuster C, et al. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy. 2007;62:884-889.
Ruëff F, Przybilla B, Biló MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol. 2009;124:1047-1054.
Agache I, Bilò M, Braunstahl G-J, et al. In vivo diagnosis of allergic diseases-allergen provocation tests. Allergy. 2015;70:355-365.

Auteurs

Maria Beatrice Bilò (MB)

Allergy Unit, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.

Matteo Martini (M)

Allergy and Clinical Immunology School, Università Politecnica delle Marche, Ancona, Italy.

Valerio Pravettoni (V)

General Medicine, Immunology and Allergy Unit - IRCCS Foudation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Donatella Bignardi (D)

UOC Allergologia Ospedale Policlinico San Martino, Genova, Italy.

Patrizia Bonadonna (P)

U.S.D. Allergology Integrated University-Hospital of Verona, Verona, Italy.

Gabriele Cortellini (G)

Allergy Unit, Internal Medicine Department, Rimini Hospital, Local Health Unit of Romagna, Rimini, Italy.

Magdalena Kosinska (M)

Department of Internal Diseases and Allergology, Medical University of Wroclaw, Wroclaw, Poland.

Donatella Macchia (D)

Allergy Unit, Hospital S. Giovanni di Dio, Florence, Italy.

Marina Mauro (M)

UOS Allergology, ASST Lariana Sant'Anna Hospital, Como, Italy.

Elisa Meucci (E)

Allergy Unit, Hospital S. Giovanni di Dio, Florence, Italy.

Marita Nittner-Marszalska (M)

Department of Internal Diseases and Allergology, Medical University of Wroclaw, Wroclaw, Poland.

Vincenzo Patella (V)

Division Allergy and Clinical Immunology, Department of Medicine ASL Salerno, "Santa Maria della Speranza" Hospital, Salerno, Italy.

Roberta Pio (R)

A.O.U San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.

Oliviero Quercia (O)

High Specialization Unit of Allergology, Hospital of Faenza, AUSL (Local Health Unit) of Romagna, Faenza, Italy.

Federico Reccardini (F)

SOC Pneumologia-Fisiopatologia Respiratoria, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.

Erminia Ridolo (E)

Allergologia e Immunologia Clinica, Dipartimento di Medicina e Chirurgia, Università degli studi di Parma, Parma, Italy.

Michael Rudenko (M)

London Allergy and Immunology Centre, London, UK.

Maurizio Severino (M)

Allergy Unit, Hospital S. Giovanni di Dio, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH